Dublin, March 08, 2024 (GLOBE NEWSWIRE) -- The "Global CBD Consumer Health Market by Product (Medical OTC Products, Nutraceuticals), Distribution Channel (Online, Retail Pharmacies, Retail Stores) - Forecast 2023-2030" report has been added to ResearchAndMarkets.com's offering.
The CBD Consumer Health Market size was estimated at USD 9.31 billion in 2022, USD 10.77 billion in 2023, and is expected to grow at a CAGR of 15.78% to reach USD 30.07 billion by 2030. 
The CBD consumer health market encompasses the sales, distribution, and consumption of cannabidiol (CBD) infused products aimed at improving overall health and wellness. The primary applications of these CBD-based products include pain management, stress relief, anxiety alleviation, and improvement in sleep quality. The increased awareness about the therapeutic benefits of CBD among consumers worldwide has improved the use of CBD consumer health products across the nutraceutical sector. Moreover, the relaxation of stringent regulations related to hemp cultivation and production has enhanced the production and availability of CBD consumer health products worldwide. The high costs associated with CBD consumer health products, along with inconsistent regulatory frameworks across different regions, have limited the product penetration of CBD consumer health products. However, the ongoing clinical trials investigating its effectiveness in treating various illnesses and continued investment from private investors and public sectors for exports and imports of medicinal CBD are expected to create growth opportunities for the CBD consumer health market in the coming years.
Regional Insights
The CBD consumer health market in the Americas is rapidly proliferating due to the legalization of cannabis cultivation and production, ongoing developments in CBD consumer health products, and increased consumer awareness toward the health benefits of CBD consumer health. Canadian consumers also show a growing interest in CBD for health and wellness purposes, as reflected by Health Canada's recent regulatory changes to provide easier access to cannabis-infused products. The rising number of clinical trials to evaluate CBD's potential benefits for various health conditions, such as anxiety, inflammation, pain management, and sleep disorders are expanding the scope for CBD consumer health products in the EMEA region. The Asia-Pacific region represents a rapidly evolving CBD consumer health market due to the flourishing nutraceutical and skincare industry, along with growing investments for CBD in the field of oncology.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the CBD Consumer Health Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the CBD Consumer Health Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
The report offers valuable insights on the following aspects
- Market Penetration: It presents comprehensive information on the market provided by key players.
- Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
- Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
- Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
- Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
Key Attributes
| Report Attribute | Details |
| No. of Pages | 193 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value (USD) in 2023 | $10.77 Billion |
| Forecasted Market Value (USD) by 2030 | $30.07 Billion |
| Compound Annual Growth Rate | 15.7% |
| Regions Covered | Global |
Key Topics Covered
- Drivers
- Legalization of Cannabis for Medicinal Purpose Across Various Countries
- Increasing Demand for CBD Nutraceuticals
- Rising Health Awareness and Increase in the Number of Retailers Selling CBD-Based Products
- Restraints
- Lack of Dose Determination Information and Negative Interaction With Other Prescriptions
- Opportunities
- Initiatives and Investment taken for Research Activity on CBD in Healthcare
- Rising Import/Export of Medicinal CBD and Expanding its Usage of CBD Topicals
- Challenges
- Availability of Alternatives, the High Price of CBD Products, and the Regulatory Concerns
Companies Mentioned
- Aurora Cannabis Inc.
- Canopy Growth Corporation
- CBD American Shaman
- CBDepot s.r.o
- Charlotte's Web Holdings, Inc.
- Columbia Care Inc.
- Croda International PLC
- Curaleaf, Inc.
- CURE Pharmaceutical Holding Corp.
- CV Sciences, Inc.
- Elixinol LLC
- Endoca BV
- Gaia Botanicals, LLC
- Global Cannabinoids Inc.
- HEXO Corp.
- Isodiol International Inc.
- Jazz Pharmaceuticals, Inc.
- Joy Organics LLC
- Kazmira LLC
- Koninklijke DSM N.V.
- Medical Marijuana, Inc.
- Medterra CBD, LLC.
- Noramco, Inc.
- NuLeaf Naturals, LLC
For more information about this report visit https://www.researchandmarkets.com/r/fgevuk
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
